1. Bagatell, C. J., McLachlan, R. I., de Krester, D. M, Burger, H. G., Vale, W. W., Rivier, J. E., and Bremner, W. J., 1989, A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men, J. Clin. Endocrinol. Metab. 69:43–48.
2. Bagatell, C. J., Conn, P. M., and Bremner, W. J., 1993, Single dose administration of the gonadotropin-releasing hormone antagonist, Nal-Lys (antide) to healthy men, Fertil. Steril. 60:680–685.
3. Bajusz, S., Kovacs, M., Gazdag, M., Bokser, L., Karashima, T., Csernus, V. J., Janaky, T., Gouth, J., and Schally, A. V., 1988, Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects, Proc. Natl. Acad. Sci. USA 85:1637–1641.
4. Behre, H. M., Bockers, A., Schlingheider, A., and Nieschlag, E., 1994, Sustained suppression of serum LH, FSH and testosterone and increase of high-density lipoprotein cholesterol by daily injection of GnRH antagonist cetrorelix over 8 days in normal men, Clin. Endocrinol. 40:241–248.
5. Bush, E. N., Nguyen, A. T., Diaz, G. J., Love, S. K., Mikusa, J. P., Cybulski, V. A., Carlson, R. P., Haviv, F., Fitzpatrick, T. D., Nichols, C. J., Swenson, R. E., Mort, N. A., Johnson, E. S., Dodge, P. W., Knittle, J., and Greer, J., 1993, Effects of A-75998 and other antagonists of gonadotropin-releasing hormone (GnRH) in castrate male rats, Endocr. J. 1:291–297.